Showing 1 to 3 of 3 results


French Court Dismisses Lawsuit Against Bayer-Monsanto Over Birth Defects
A French court dismissed a lawsuit against Bayer-Monsanto by the Grataloup family, whose son Théo suffered severe birth defects after his mother used Monsanto's Glypher herbicide eight months before his birth. The court found insufficient evidence linking the herbicide to Théo's condition, despite a...
French Court Dismisses Lawsuit Against Bayer-Monsanto Over Birth Defects
A French court dismissed a lawsuit against Bayer-Monsanto by the Grataloup family, whose son Théo suffered severe birth defects after his mother used Monsanto's Glypher herbicide eight months before his birth. The court found insufficient evidence linking the herbicide to Théo's condition, despite a...
Progress
60% Bias Score


Glyphosate's EU Authorization Amidst Cancer Concerns
French farmer Ludovic Maugé's intravascular B-cell lymphoma, linked to glyphosate exposure, highlights the ongoing controversy surrounding the herbicide's authorization by the EU until 2033, despite research indicating a link to cancer.
Glyphosate's EU Authorization Amidst Cancer Concerns
French farmer Ludovic Maugé's intravascular B-cell lymphoma, linked to glyphosate exposure, highlights the ongoing controversy surrounding the herbicide's authorization by the EU until 2033, despite research indicating a link to cancer.
Progress
56% Bias Score

Glyphosate's EU Authorization Extension Amidst Cancer Concerns
Ludovic Maugé, a French citizen, developed a rare cancer linked to 30 years of glyphosate exposure; his case highlights the controversy surrounding the herbicide's authorization by the EU until 2033, despite its classification as "probably carcinogenic" by the IARC.

Glyphosate's EU Authorization Extension Amidst Cancer Concerns
Ludovic Maugé, a French citizen, developed a rare cancer linked to 30 years of glyphosate exposure; his case highlights the controversy surrounding the herbicide's authorization by the EU until 2033, despite its classification as "probably carcinogenic" by the IARC.
Progress
60% Bias Score
Showing 1 to 3 of 3 results